ライフサイエンスコーパス: shunt

1 synthesis (which we refer to as the glycogen shunt).

2 DA) stent or a modified Blalock-Taussig (BT) shunt.

3 hibiting entry of carbon into the glyoxylate shunt.

4 o pre-existing causes other than the aqueous shunt.

5 vival advantage to mice following aortocaval shunt.

6 acilitate glucose breakdown is the gluconate shunt.

7 capillary bed through anatomic right-to-left shunts.

8 ypoxic areas, likely resulting from vascular shunts.

9 well controlled since the placement of tube shunts.

10 nts indicated the presence of porto-systemic shunts.

11 d stenting or angioplasty of Blalock-Taussig shunts.

12 r failure in two, with major portal-systemic shunts.

13 f whom 81% had moderate or large interatrial shunts.

14 g the physiologic effects during interatrial shunting.

15 ry sensitive to detect even small degrees of shunting.

16 capillaries and extensive arteriolar-venular shunting.

17 ere assigned to undergo ventriculoperitoneal shunting.

18 Twelve shunts (2 shunt runs per pig) were run comparing the 3 s

19 ty (31%), liver disease (23%), arteriovenous shunts (23%), lung disease (16%), and myeloproliferative

20 Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabecul

21 d randomly assigned to treatment with a tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabecul

22 Using a simple model we show how shunting a proportion of the tunnelling current through

23 We propose that the glycogen shunt, a pathway recently shown to be critical for cance

24 ikely by interfering with AA cyclization and shunting AA to the LOX pathway under physiological condi

25 e periphery (avascular area, vessel leakage, shunts, abnormal vessel branching, and tangles) or the p

26 wn whether catabolic by-products of the GABA shunt actually support metabolic homeostasis.

27 uced in 7-day-old rabbits via an aorto-caval shunt, after which, the rabbits were treated with or wit

28 A so-called modified Blalock-Taussig shunt allows progress through early life to an age and w

29 and 2) is the first enzyme of the glyoxylate shunt, an essential pathway for Mycobacterium tuberculos

30 up-regulation of the gamma-aminobutyric acid shunt and alanine metabolism explained the accumulation

31 supine infant with a ventricular-peritoneal shunt and controlled occlusions.

32 Treatment options include shunt and endoscopic approaches, which should be individ

33 y driving carbon flux through the glyoxylate shunt and gluconeogenesis and into synthesis of trehalos

34 measures between patients with and without a shunt and minimal differences between patients with and

35 ar septal defects with exclusive ventricular shunting and demonstrate that, contrary to current hypot

36 ial distributions for the assessment of lung shunting and extrahepatic uptake.

37 thromboembolism, dissection and intracardiac shunting and mass effect over adjacent cardiovascular st

38 ance in treating brain injuries treated with shunts and has the potential to bring significant impact

39 er-treated eyes, leakage was noted in 1 eye, shunts and tangles were noted in 3 eyes, and macular abn

40 inflammation, loss of lung volume, increased shunt, and diffuse alveolar damage-are also present in s

41 atients underwent a modified Blalock-Taussig shunt, and in 83 patients, DS was attempted.

42 ly assigned 555 patients to one or the other shunt, and these subjects continue to be followed closel

43 icoenteric arterial anatomy, hepatopulmonary shunting, and appropriate dosimetry considerations.

44 nternal ribosome entry site (IRES), ribosome shunting, and eIF4G enhancers.

45 frequently caused by obesity, arteriovenous shunts, and liver disease.

46 lium also led to dilated sinusoids, vascular shunts, and necrosis, albeit milder than that observed i

47 onary conditions, patients with intracardiac shunts, and special patient populations including pulmon

48 between nutrient and carbon cycling-a "lipid shunt," and its direct transport of carbon through the m

49 All shunted animals developed PH.

50 al fibrillation (AF) as a result of residual shunts, anomalous vessel anatomy, progressive valvulopat

51 Benson cycle and its photorespiratory repair shunt are in charge of nearly all biological CO2 fixatio

52 t in the right ventricle-to-pulmonary artery shunt as the source of pulmonary blood flow, rather than

53 cupin-like DMSP lyase, DddK, simultaneously shunts as much as 59% of DMSP uptake to dimethyl sulfide

54 se provides a more accurate and precise lung shunt assessment.

55 arboxylic acid (TCA) cycle intermediates are shunted away for the synthesis of biological molecules r

56 and an accompanying alternative porto-caval shunt between the right portal vein and inferior vena ca

57 absence of respiratory system cooling of the shunted blood and that this effect would be dependent up

58 and evaporative heat loss, so right-to-left shunted blood flow through a patent foramen ovale (PFO)

59 by absence of respiratory system cooling of shunted blood.

60 hibition via sodium channel inactivation and shunting but can evoke spikes under certain conditions.

61 nventional treatment is ventriculoperitoneal shunting, but surgeons are usually not immediately avail

62 Disconnection of the portacaval shunt by left renal vein ligation (LRVL) is another opti

63 We avoid unwanted charge current shunting by the low resistive NM layer utilizing the new

64 rocedures or situations: cerebrospinal fluid shunts, cerebrospinal fluid drains, implantation of intr

65 oelectric self-sensing system by integrating shunting circuitry into conventional sensors.

66 EX-PRESS shunt, compared to trabeculectomy and Ahmed valve, seems

67 lly proposed that they would provide a Cl(-) shunt conductance allowing efficient acidification of in

68 patch and microelectrode data arises from a shunt conductance was tested using the dynamic clamp in

69 Modified Blalock-Taussig shunts continue to present concern for postprocedural in

70 as an intercellular signal and that pyruvate shunting contributes to aerobic lactate production by as

71 by Fontan operation and 2 by aortopulmonary shunts: d-transposition of the great arteries after Must

72 dications, and had significant right-to-left shunt defined by transcranial Doppler.

73 with an implanted left-to-right interatrial shunt demonstrates initial safety and early beneficial c

74 observational studies reported reductions in shunt dependency for a combined treatment approach of IV

75 and significantly reduces rates of permanent shunt dependency for aresorptive hydrocephalus post-ICH.

76 rhage (ICH) and is associated with permanent shunt dependency in a substantial proportion of patients

77 ned strategy-IVF plus LD versus IVF alone-on shunt dependency in patients with ICH and severe IVH.

78 Meta-analyses on shunt dependency showed an absolute risk reduction of 24

79 moval, particularly TSSR when the patient is shunt dependent, remains the optimal choice of treatment

80 n-label studies, a transcatheter interatrial shunt device (IASD, Corvia Medical) was associated with

81 ce and safety of a transcatheter interatrial shunt device (IASD, Corvia Medical, Tewkesbury, MA, USA)

82 A novel transcatheter interatrial shunt device has been developed and evaluated in patient

83 One year after interatrial septal shunt device implantation, there were sustained improvem

84 ion patients 1 year after interatrial septal shunt device implantation.

85 for a therapeutic transcatheter interatrial shunt device in HFpEF, and we describe the design of RED

86 Implantation of an interatrial shunt device is feasible, seems to be safe, reduces left

87 demonstrated that a novel interatrial septal shunt device that allows shunting to reduce the left atr

88 e open-label study of the interatrial septal shunt device.

89 Aortocaval shunt did not further impact cardiomyocyte number in mic

90 Mini-shunts done via an external approach (including ExPRESS

91 f yeast with a partial block in the glycogen shunt due to the cif mutation, which found that when cha

92 The high rate of shunt dysfunction with the use of uncovered stents count

93 me (BCS), and to determine the predictors of shunt dysfunction.

94 DP-ribose) polymerase, which inhibits GAPDH, shunting early glycolytic intermediates into pathogenic

95 neurons, published ChloCs produced a strong shunting effect but also a small, yet significant depola

96 ated chloride channels is mediated mainly by shunting effects, which exert optogenetic control much m

97 t increase in use include canaloplasty, mini-shunts (external approach), aqueous shunt to extraocular

98 Techniques for ascertaining shunt failure are time-consuming, expertise-dependent, a

99 Atorvastatin decreased portal pressure, shunt flow and angiogenesis in cirrhosis, whereas atorva

100 Shunt flow by CMR strongly correlated with PH severity,

101 ast, as critical for regulating the glycogen shunt flux.

102 o scaffolds/stents and allowed to run in the shunt for a maximum of 1 hour.

103 tion and non-generic usage of the glyoxylate shunt for hypoxic fitness.

104 er comparison of palliative PDA stent and BT shunt for infants with ductal-dependent pulmonary blood

105 ing as a preferred alternative to a surgical shunt for neonatal palliation with evidence for greater

106 ow, rather than the modified Blalock-Taussig shunt for the Norwood.

107 Purpose To determine if high lung shunt fraction (LSF) is an independent prognostic indica

108 microsphere delivery, and reducing the lung-shunt fraction are discussed.

109 ke, without the requirement for an increased shunt fraction during expiration.

110 The P/F ratio, vascular/airway parameters, shunt fraction, alveolar-arterial gradient and oxygenati

111 /F ratio, higher pulmonary compliance, lower shunt fraction, lower alveoli-arterial gradient and lowe

112 ing expiration in the presence of a variable shunt fraction, such as with cyclical atelectasis, but i

113 The relationship of PaO2/FIO2 varies at all shunt fractions but most with QS/QT from 0.1 to 0.3 with

114 mium-exposed A2780 cells undergo a metabolic shunt from glycolysis to oxidative phosphorylation, wher

115 ow palliated with either a PDA stent or a BT shunt from January 2008 to November 2015 were reviewed f

116 An electron transfer shunt from the electrode circumvents the slow dissociati

117 nt of IOL-CB dislocation can modify glaucoma shunt function.

118 nd brain that demonstrates that the glycogen shunt functions to maintain homeostasis of glycolytic in

119 dynamics of the sigmaB-regulated glyoxylate shunt gene expression in Mycobacterium tuberculosis cell

120 gamma-aminobutyric acid (GABA), in the GABA shunt generates catabolites that may enter the tricarbox

121 nzyme in CPT biosynthesis which specifically shunts geraniol into the secologanin pathway was also cl

122 In this shunt glucose dehydrogenase and gluconate kinase catalyz

123 at in S. pombe Gcd1 and Idn1 act together to shunt glucose into the pentose phosphate pathway, creati

124 e ETV-CPC group and the ventriculoperitoneal-shunt group in BSID-3 motor or language scores, rates of

125 depended on full activity of the glyoxylate shunt (GS), which enables synthesis of trehalose from ac

126 saturation (indicating greater right-to-left shunting); higher transferrin iron saturation index; int

127 4 for ETV-CPC and 2 for ventriculoperitoneal shunting; Hodges-Lehmann estimated difference, 0; 95% co

128 % CI, 1.03 to 1.11), and cerebrospinal fluid shunting (HR, 2.02; 95% CI, 1.07 to 3.78) were associate

129 uations at baseline and months 1 and 3 after shunt implantation.

130 Shunt implants were done after transseptal catheterisati

131 The novel role proposed for the glycogen shunt implicates the high activities of glycogen synthas

132 n were compromised in response to aortocaval shunt in both WT and cyclin D2-expressing mice.

133 ction (TAC) or volume overload by aortocaval shunt in cyclin D2-expressing and WT mice.

134 PDA stent as a reasonable alternative to BT shunt in select patients.

135 These data indicate a role of the GABA shunt in the development of metabolic risk and suggest t

136 Similarities between the glycogen shunt in yeast and cancer cells lead us here to propose

137 h disclosed virtually complete portosystemic shunting in Fut2(-/-)(high) mice, discrete portosystemic

138 Fut2(-/-)(high) mice, discrete portosystemic shunting in Fut2(-/-)(low) mice, and no shunting in wt l

139 Prolonged systemic-to-pulmonary shunting in growing piglets induces PH with biventricula

140 acy of therapeutic left-to-right interatrial shunting in patients with heart failure with reduced eje

141 septal myocardium, leading to left-to-right shunting in the form of ventricular septal defect and pa

142 es after ETV-CPC versus ventriculoperitoneal shunting in Ugandan infants with postinfectious hydrocep

143 emic shunting in Fut2(-/-)(low) mice, and no shunting in wt littermates.

144 nical experience with congenital interatrial shunts in mitral stenosis, it has been hypothesized that

145 l study of patients aged >/=12 years with VP shunt infections (1980 -2014).

146 This is the largest series of VP shunt infections in adults reported to date.

147 timal treatment of ventriculoperitoneal (VP) shunt infections in adults.

148 artate-aminotransferase, a key enzyme of the shunt, inhibited nitric oxide and interleukin-6 producti

149 embrane conductance is also increased during shunting inhibition, which accompanies the classic GABAA

150 ls (ECs) have a hyper-glycolytic metabolism, shunting intermediates to nucleotide synthesis.

151 analytical sensitivity by integrating sponge shunt into LFA to decrease the fluid flow rate.

152 EPO produced in CHO cells can be improved by shunting intracellular CMP-Neu5Ac away from GSL biosynth

153 The glyoxylate shunt is a metabolic pathway of bacteria, fungi, and pla

154 This energy shunt is consequential to the overall productivity of hy

155 One of the key shunts is the exit of citrate from the mitochondria and

156 se (MS), the second enzyme of the glyoxylate shunt, is essential for in vitro growth and survival of

157 owed that the first enzyme of the glyoxylate shunt, isocitrate lyase (ICL), may mediate survival of M

158 Loss of the glycogen shunt leads to cell death under substrate stress.

159 biodistribution (liver, lung) and liver-lung shunt (LLS) of both tracers (12 patients each) were asse

160 flow of matter and energy through the viral shunt may be decreased with consequences for the Antarct

161 over, BA derivatives undergoing cholehepatic shunting may allow improved targeting to the bile ducts.

162 egenerative disorders in which benefits from shunting may be short-lived, with a consequently unfavor

163 s lost in FRET experiments and culminates in shunting migration in a fibrous fibronectin matrix.

164 An ex-vivo porcine arterio-venous shunt model was used to assess platelet aggregation, whe

165 rug-eluting stent in a porcine arteriovenous shunt model.

166 scaffold in an ex vivo porcine arteriovenous shunt model.

167 tricular exclusion and systemic to pulmonary shunt (modified Starnes procedure).

168 de functions involved in the so-called bifid-shunt, most enzymes related to nucleotide biosynthesis a

169 n=10) followed by intracardiac right-to-left shunt (n=5).

170 s was studied in 20 animals (aorto-pulmonary shunt [n=10] or sham operation [n=10]) 3 months after th

171 cardiac adaptation, 12 pigs (aorto-pulmonary shunt [n=6] or sham operation [n=6]) were evaluated mont

172 that moths generate antioxidant potential by shunting nectar glucose to the pentose phosphate pathway

173 on transport is balanced out by paracellular shunting of acid/base.

174 seem to not take into account arterio-venous shunting of amino acids, which comprises approximately 8

175 t ammonia accumulation that results from the shunting of arginine catabolism into alternative nitroge

176 Non-depolarizing shunts of 3-10 nS converted cells from classes 1 and 2 t

177 s of age undergoing either a Blalock-Taussig shunt or a DS for cardiac conditions with duct-dependent

178 tients undergoing a modified Blalock-Taussig shunt or a DS in infants with duct-dependent pulmonary b

179 Patients undergoing surgical shunt or ductal stent were less likely to have virtual a

180 ion (splenic artery ligation, hemiportocaval shunt, or splenectomy) was performed at the discretion o

181 ood flow (61% of PDA stents versus 38% of BT shunts; P<0.001).

182 lation in 60% of PDA stents versus 45% of BT shunts; P=0.001) and presence of antegrade pulmonary blo

183 dehydrogenase in the gamma-aminobutyric acid shunt pathway and an aconitase family protein involved i

184 1-catalyzed reaction, we tested the peroxide shunt pathway by using rapid kinetic techniques to monit

185 ly activated Entner-Doudoroff and glyoxylate shunt pathways are shown here to represent no real incre

186 pulmonary regurgitation, indicating circular shunt physiology, are a high-risk cohort and may benefit

187 A year after her tube shunt placement in the left eye, ultrasound biomiscropy

188 The primary endpoint consisted of permanent shunt placement indicated after a total of three unsucce

189 Hydrocephalus with shunt placement was associated with impaired intelligenc

190 ion, transjugular intrahepatic portosystemic shunt placement, balloon retrograde transvenous oblitera

191 ocephalus that required ventriculoperitoneal shunt placement, with a subsequent shunt revision at age

192 hocardiographic parameters for assessment of shunt presence, shunt volume and its effect on cardiovas

193 vo and in vitro production of seongomycin, a shunt product from this pathway, and stealthin C, a prop

194 We suggest endocrocin is likely a shunt product in all related non-reducing polyketide syn

195 ert strictosidine to akuammicine, the stable shunt product of preakuammicine.

196 hout Ind6, the pathway derails to an unusual shunt product.

197 cation of extended but prematurely offloaded shunt products suggested that the Pik thioesterase (TE)

198 , mesenteric vascular density, portosystemic shunting (PSS), intrahepatic angiogenesis, and fibrosis

199 uding portal pressure (PP) and portosystemic shunts (PSS), and collected tissues for histomorphology,

200 y at 6 months was confirmed by left-to-right shunting (pulmonary/systemic flow ratio: 1.06 [SD 0.32]

201 several degrees of increased intrapulmonary shunting (QS/QT), assessing the impact of intra- and ext

202 ricular volume and function, stress imaging, shunt quantification, and tissue characterization.

203 gy to hasten clot resolution that may reduce shunt rates.

204 ntent in lung tissues of rat were reduced in shunt rats with high pulmonary blood flow.

205 ive collagen accumulation in lung tissues of shunt rats.

206 A P450 hydroperoxide-shunt reaction is proposed, where the hydroperoxides ser

207 nts carried out at very low temperatures and shunt reactions, but their presence has not yet been val

208 at predicted failure was retention of the VP shunt, regardless of the strategy.

209 SR), two-stage shunt replacement (TSSR), and shunt removal without replacement (SR).

210 VP shunt removal, particularly TSSR when the patient is shu

211 This residue acts as a kinetic switch, shunting repair toward long-patch BER upon correct dCMP

212 4 headings: only antibiotics (OA), one-stage shunt replacement (OSSR), two-stage shunt replacement (T

213 ne-stage shunt replacement (OSSR), two-stage shunt replacement (TSSR), and shunt removal without repl

214 TSSR was the most effective strategy when VP shunt replacement was attempted.

215 nal radiative efficiency, series resistance, shunt resistance and catalytic exchange current density-

216 thin 1-5 months of the MR examination) in 36 shunt-responsive patients with normal-pressure hydroceph

217 llular property but a dynamic consequence of shunting resulting from electrical coupling.

218 s dominated by consequences of portosystemic shunting resulting in microcirculatory disturbances, mil

219 performed at the time of the right eye tube shunt revealed extensive ciliary body cysts in the right

220 eritoneal shunt placement, with a subsequent shunt revision at age 6 years.

221 patients transplanted with large splenorenal shunts, RPA and LRVL reach similar survivals.

222 Twelve shunts (2 shunt runs per pig) were run comparing the 3 scaffolds i

223 oups while adjusting for variability between shunt runs.

224 nd in those with a substantial right-to-left shunt size (hazard ratio, 0.19; 95% confidence interval,

225 nd in those with a substantial right-to-left shunt size, deserves further investigation.

226 aft in patients with spontaneous splenorenal shunts (SRS) is a matter of concern especially in case o

227 We conclude that by shunting substantial amounts of carbohydrate into urine,

228 Trabeculectomy and tube shunt surgery had similar impact on patient-reported vis

229 on disease usually treated by suboptimal CSF shunting techniques.

230 ive variant of the aspartate-arginosuccinate shunt that compensated for this break.

231 ate- and mannitol/sucrose-based bioenergetic shunt that greatly minimizes false-positive hits, we ide

232 vitamin B12-independent propionate breakdown shunt that is transcriptionally activated on vitamin B12

233 nsistent with the theory of distal dendritic shunting-that can regulate the robustness of sensory-evo

234 s transmembrane conductance regulator, which shunt the transmembrane potential generated by movement

235 ermeable channel in the AM also functions to shunt the transmembrane potential generated by proton pu

236 GDH) is the metabolic enzyme responsible for shunting the glycolytic intermediate 3-phosphoglycerate

237 hese conditions, cells maintain viability by shunting the reaction through an aberrant recombinationa

238 e to 3-hydroxykynurenine, and its inhibition shunts the kynurenine pathway-which is implicated as dys

239 atrial septal aneurysm or large interatrial shunt, the rate of stroke recurrence was lower among tho

240 uated thrombosis weight in an arterio-venous shunt thrombosis model by 57.91%, both at a dose of 3 mg

241 r postoperative evaluation and management of shunt thrombosis or stenosis.

242 nd pentose phosphate pathway, the glucose is shunted through the HBP.

243 se experiments show that not all catalyst is shunted through the off-cycle intermediates and this con

244 ransjugular intrahepatic portosystemic stent-shunt (TIPS) (8 mm; n = 90), or medical reduction of por

245 y of transjugular intrahepatic portosystemic shunt (TIPS) as a treatment for BCS with diffuse occlusi

246 of a transjugular intrahepatic portosystemic shunt (TIPS) correlates with the absence of further blee

247 fter transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with cirrhosis with Mo

248 s of transjugular intrahepatic portosystemic shunt (TIPS) creation performed by using a 10-mm or an 8

249 t in transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic portal hypertension.

250 y of transjugular intrahepatic portosystemic shunt (TIPS) in a series of patients with Budd-Chiari sy

251 y of transjugular intrahepatic portosystemic shunt (TIPS) in this population are unknown.

252 fter transjugular intrahepatic portosystemic shunt (TIPS) placement.

253 PVR)-transjugular intrahepatic portosystemic shunt (TIPS) to potentiate LT.

254 e of transjugular intrahepatic portosystemic shunt (TIPS) with covered stents in patients receiving s

255 ransjugular intrahepatic portosystemic stent shunt (TIPS).

256 of a transjugular intrahepatic portosystemic shunt (TIPS).

257 with transjugular intrahepatic portosystemic shunt (TIPS).

258 oing transjugular intrahepatic portosystemic shunt (TIPS).

259 y of transjugular intrahepatic portosystemic shunts (TIPS) to increase survival times of patients wit

260 y of transjugular intrahepatic portosystemic shunts (TIPS) to increase survival times of patients wit

261 the creation of a left-to-right interatrial shunt to decompress the left atrium (without compromisin

262 A shunt to drain the fluid into a body cavity is now unive

263 ty, mini-shunts (external approach), aqueous shunt to extraocular reservoir, and ECP.

264 nd a variable contribution of the glyoxylate shunt to non-replicative, hypoxic survival between the t

265 5% CI, -0.83 to 0.28; P = 0.32), and aqueous shunt to reservoir (elasticity, -0.47; 95% CI, -3.32 to

266 evelopment, with simple sugars instead being shunted to the hematopoetic organ for rapid conversion i

267 interatrial septal shunt device that allows shunting to reduce the left atrial pressure provides cli

268 to late failure but is also less likely than shunting to result in a reduction in ventricular size th

269 The number of aqueous shunts to the extraocular reservoir increased 231% from

270 al evidence of a distinct in vivo "rPFOR-PFL shunt" to reduce CO2 to formate while circumventing the

271 atrial septal aneurysm or large interatrial shunt, to transcatheter PFO closure plus long-term antip

272 nfected rats and cultured astroglioma cells, shunting tryptophan degradation toward the production of

273 mal timing of S2P existed when stratified by shunt type.

274 icuspid regurgitation, arch obstruction, and shunt type.

275 The glycogen shunt uses glycolytic ATP to store glycolytic intermedia

276 rcine model of PH because of aorto-pulmonary shunt using cardiac magnetic resonance (CMR).

277 monary blood flow are often palliated with a shunt usually between the subclavian artery and either p

278 fences in humans are sweating, arteriovenous shunt vasoconstriction, and shivering.

279 aluation revealed the presence of paraportal shunting vessels, increased numbers of portal vascular s

280 lism and can feed into either the glyoxylate shunt (via isocitrate lyase) or the TCA cycle (via isoci

281 parameters for assessment of shunt presence, shunt volume and its effect on cardiovascular and hemody

282 A side-to-side arteriovenous (AV) shunt was created between the distal stump of one of the

283 x vivo porcine carotid jugular arteriovenous shunt was established and connected to SYLGARD tubing co

284 A tube shunt was placed to control the elevated IOP.

285 controlled with medications alone and a tube shunt was similarly placed in the right eye.

286 Portosystemic shunting was demonstrated by portal angiography, which d

287 Intrahepatic lobe shunting was present on NMI in only 2.9% of the cases bu

288 in strains lacking enzymes of the gluconate shunt we demonstrate that Gcd1 encodes a novel NADP(+)-d

289 with a PDA stent and 251 patients with a BT shunt were included.

290 ess, length and hydrophobicity of the sponge shunt were sequentially optimized, and achieved 10-fold

291 echocardiography at 1 month showed that all shunts were patent, with no thrombosis or migration.

292 patients with ES, all with a post-tricuspid shunt, were enrolled in a prospective, longitudinal, sin

293 usually not immediately available to revise shunts when they fail.

294 Hypoxemia is mainly due to intrapulmonary shunt, whereas increased alveolar dead space explains th

295 trial flow, this may lead to a right-to-left shunt, which becomes physiologically apparent only when

296 metabolism, and the gamma-aminobutyric acid shunt, while [(13)C]glutamate and [(15)N]ammonium labeli

297 -containing isozyme catalyzes an off-pathway shunt with the same substrates, generating methylthiopro

298 endoscopic ETV-CPC and ventriculoperitoneal shunting with regard to cognitive outcomes at 12 months.

299 R imaging demonstrated arterio-portal-venous shunting, with draining into the TIPS.

300 lesions arising from direct arterial-venous shunts without intervening capillaries.